- Home
- GHRS vs EQBK Comparison
GHRS vs EQBK Comparison
Compare GHRS & EQBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GHRS
- EQBK
- Stock Information
- Founded
- GHRS 2018
- EQBK 2002
- Country
- GHRS Ireland
- EQBK United States
- Employees
- GHRS N/A
- EQBK N/A
- Industry
- GHRS Biotechnology: Pharmaceutical Preparations
- EQBK Major Banks
- Sector
- GHRS Health Care
- EQBK Finance
- Exchange
- GHRS Nasdaq
- EQBK Nasdaq
- Market Cap
- GHRS 874.0M
- EQBK 773.5M
- IPO Year
- GHRS 2021
- EQBK 2015
- Fundamental
- Price
- GHRS $12.22
- EQBK $41.22
- Analyst Decision
- GHRS Strong Buy
- EQBK Buy
- Analyst Count
- GHRS 8
- EQBK 6
- Target Price
- GHRS $30.63
- EQBK $46.20
- AVG Volume (30 Days)
- GHRS 183.0K
- EQBK 91.0K
- Earning Date
- GHRS 08-07-2025
- EQBK 10-14-2025
- Dividend Yield
- GHRS N/A
- EQBK 1.43%
- EPS Growth
- GHRS N/A
- EQBK 532.31
- EPS
- GHRS N/A
- EQBK 4.01
- Revenue
- GHRS N/A
- EQBK $227,628,000.00
- Revenue This Year
- GHRS N/A
- EQBK $19.34
- Revenue Next Year
- GHRS N/A
- EQBK $11.25
- P/E Ratio
- GHRS N/A
- EQBK $10.49
- Revenue Growth
- GHRS N/A
- EQBK 48.83
- 52 Week Low
- GHRS $6.00
- EQBK $34.11
- 52 Week High
- GHRS $20.50
- EQBK $50.85
- Technical
- Relative Strength Index (RSI)
- GHRS 37.28
- EQBK 53.11
- Support Level
- GHRS $13.71
- EQBK $41.52
- Resistance Level
- GHRS $14.59
- EQBK $42.31
- Average True Range (ATR)
- GHRS 0.73
- EQBK 0.93
- MACD
- GHRS -0.09
- EQBK 0.02
- Stochastic Oscillator
- GHRS 4.62
- EQBK 41.44
About GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About EQBK Equity Bancshares Inc.
Equity Bancshares Inc is a bank holding company. It provides a broad range of financial services to businesses and business owners as well as individuals through network of nearly 71 branches located in Arkansas, Kansas, Missouri and Oklahoma. The majority of the Company's revenues come from interest income on financial instruments, including loans, leases, securities and derivatives. The company also earns revenue from Non-interest income which includes Service charges and fees, Debit card income, Investment Referral Income, Trust Income and Insurance Sales Commissions.